Award
National Institute of Neurological Disorders and Stroke 5R01NS123808-04
Retroviral RLI immunomodulatory gene therapy for glioblastoma
Recipient
Not Specified
Award Amount
$403,750.00
Ceiling
$403,750.00
Awarded
August 15, 2025
Identifier
5R01NS123808-04
Award for a gene therapy project targeting glioblastoma using retroviral RLI to enhance immune response, funded by NIH/NINDS.
Description
The project involves immunomodulatory gene therapy for glioblastoma using retroviral delivery of RLI. The project aims to enhance immune responses against glioblastoma.